ORMUTIVIMAB
UNII N7NY3SG25X

Substance Identification & Data

This profile provides standardized clinical and technical data for Ormutivimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N7NY3SG25X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2449086-91-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N7NY3SG25X
CAS Registry Number
2449086-91-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ORMUTIVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C184868
National Cancer Institute reference terminology for clinical and research data.
INN ID
11825
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ormutivimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ORMUTIVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(RABIES LYSSAVIRUS GLYCOPROTEIN EPITOPE G-I) (HUMAN MONOCLONAL NM57 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NM57 .LAMBDA.-CHAIN, DIMER
ORMUTIVIMAB [INN]
ORMUTIVIMAB [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus